Who owns AYTU BIOPHARMA INC?

Tip: Access positions for across all investors

Analyze quarterly positions in Aytu Biopharma with up to 7 years of data, all consolidated into one spreadsheet

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Top investors of Aytu Biopharma stock

Who bought or sold AYTU BIOPHARMA INC this quarter?

Fund or Company Name Shares Held Valued At Change in Shares As Of Actions
Nantahala Capital Management 1.1M $2.8M 0% Dec 2025
 View chart
Stonepine Capital Management 814k $2.1M -9% Dec 2025
 View chart
AWM Investment Company 620k $1.6M 0% Dec 2025
 View chart
Vanguard Group 279k $724k 0% Dec 2025
 View chart
Diadema Partners 273k $513k 100% Sep 2025
 View chart
Renaissance Technologies 90k $233k -6% Dec 2025
 View chart
Geode Capital Management 74k $193k 4% Dec 2025
 View chart
Two Sigma Investments 69k $129k 96% Sep 2025
 View chart
Persistent Asset Partners 63k $117k 100% Sep 2025
 View chart
Two Sigma Advisers 40k $75k 100% Sep 2025
 View chart
Dimensional Fund Advisors 35k $92k 14% Dec 2025
 View chart
FNY Investment Advisers 32k $82k 24208% Dec 2025
 View chart
DRW Holdings 29k $76k 100% Dec 2025
 View chart
XTX Topco 26k $67k 100% Dec 2025
 View chart
Bellevue Asset Management 25k $65k 100% Dec 2025
 View chart
BlackRock 23k $43k 0% Sep 2025
 View chart
Sentinus 20k $52k 100% Dec 2025
 View chart
Northern Trust 19k $50k 100% Dec 2025
 View chart
Acadian Asset Management 10k $26k 0% Dec 2025
 View chart
MAI Wealth Advisors 3.6k $9.3k 0% Dec 2025
 View chart
UBS Group 3.0k $7.9k -3% Dec 2025
 View chart
Tower Research Capital 1.7k $4.5k -60% Dec 2025
 View chart
Advisor Group Holdings 460.00 $1.2k 1% Dec 2025
 View chart
Wells Fargo & Company 127.00 $328.079100 0% Dec 2025
 View chart
Atlantic Trust 83.00 $215.999200 0% Dec 2025
 View chart
SBI Securities 62.00 $117.000200 -71% Sep 2025
 View chart
Group One Trading 37.00 $96.000200 0% Dec 2025
 View chart
Bnp Paribas Arbitrage, Snc 23.00 $60.000100 0% Dec 2025
 View chart
Goss Wealth Management 21.00 $54.999000 0% Dec 2025
 View chart
FMR 5.00 $9.000000 100% Sep 2025
 View chart
Vision Financial Markets 2.00 $6.000000 0% Dec 2025
 View chart
TSFG 1.00 $0 0% Dec 2025
 View chart
Jones Financial Companies, L.L 1.00 $2.000000 0% Sep 2025
 View chart

Who sold out of Aytu Biopharma?

Fund or Company Name Date Sold Shares Held Valued At
Jaffetilchin Investment Partners Sep 2025 17k $33k
Raymond James Financial Jun 2025 55.00 $120.230000
Barclays Sep 2025 1.00 $2.000000